Special Care Dental Of Pennsylvania-ckk Llc Dentist Medicare: Not Enrolled in Medicare Practice Location: 11974 Edgehill Terrace Rd, Princess Anne, MD 21853 Phone: 502-244-2420 Fax: 502-996-8282 |
News Archive
Oncothyreon Inc. today announced that it has priced an underwritten public offering of 10,000,000 shares of its common stock at a price to the public of $4.00 per share for gross proceeds of $40.0 million. The net proceeds from the sale of the shares, after deducting the underwriters' discounts and other estimated offering expenses payable by Oncothyreon, will be approximately $37.4 million.
This is pointed out by the German Federal Institute for Risk Assessment (BfR) following the frequent occurrences of severe lung disorders amongst "vapers" in the USA. "According to current understanding, e-cigarette consumers in Germany do not face any increased risks, provided they continue to use products that comply with European and German regulations," says BfR President Professor Dr. Dr. Andreas Hensel."
Advaxis, Inc.,, a leader in developing the next generation of cancer immunotherapies, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated head and neck cancer.
Viragen, Inc. today announced that the Company extended its agreement with the University of Miami and UM/Sylvester Comprehensive Cancer Center to develop a novel form of an immune enhancing drug (IEP 11) that has shown promise in animal studies by inhibiting tumor growth in a broad range of cancers.
› Verified 4 days ago